Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine Butyrate Injectable Emulsion in Hypertensive Emergencies and Urgencies
CTR20221116Phase 3Completed
- Sponsor
- Chengdu Huide Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in hypertensive emergency, hypertensive urgency, hypertension (HTN), sponsored by Chengdu Huide Pharmaceutical. Started May 2022; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertensive emergencyhypertensive urgencyhypertension (HTN)
Beyond the preview
Go deeper on CTR20221116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221116.